Persistent nasal allergy is more than seasonal sneezing.
Chronic allergic rhinitis sits at the entry point of the type 2 inflammatory spectrum — frequently coexisting with asthma, sinus disease and ocular allergy. Long-term control deserves a specialty-level approach.
How it affects daily life
Beyond congestion and sneezing, persistent allergic rhinitis disrupts sleep, concentration, productivity and exercise tolerance — and silently amplifies coexisting asthma and sinus disease.
When to seek specialized evaluation
- Daily symptoms despite intranasal steroids and antihistamines
- Persistent congestion or smell impairment
- Coexisting asthma, eczema, sinus disease or ocular allergy
- Repeated antibiotic or oral steroid courses for sinus symptoms
- Interest in immunotherapy or disease-modifying options
How we evaluate
We characterize the inflammatory pattern (perennial vs seasonal), screen for type 2 comorbidities, review prior testing (skin prick, specific IgE), and orient on allergen immunotherapy and biologic candidacy when severe overlap with asthma or CRSwNP is present.
Advanced treatment options
Beyond symptomatic medication, modern care includes structured allergen immunotherapy (subcutaneous and sublingual) and — in severe disease overlapping with asthma, polyps or eczema — biologic therapies that act on shared type 2 pathways.
Allergic rhinitis is rarely isolated.
Persistent rhinitis often signals a broader type 2 inflammatory pattern. Recognizing it early reframes long-term management beyond reactive symptom relief.
